公司资料
Axon Enterprise, Inc. 股价、新闻与催化剂
- 股票代码:
- AXON
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
306.98 USD (+2.09%)
收盘价
最后更新: 2026年11月19日
39.5B USD
市值
股价为何变动
最新公司动态“Connected for Safety: How State and Local Agencies Across the Country Are Modernizing Public Safety with Axon”发布后,AXON 于 2026年11月19日 收于 $306.98,较前一交易日上涨 2.09%。该变动发生在与这则公司动态对应的交易时段。
公司概览
业务概览
Axon Enterprise is a public safety technology company best known for its TASER devices, body cameras, and cloud software for law-enforcement workflows. Its business is built around hardware plus recurring software and services.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Axon has a growing global public-safety footprint. It is not a biotech or medtech company, but a public-safety technology platform.
商业模式特征
The company generates revenue through devices, software subscriptions, evidence management, and related services. Investors watch product adoption, recurring software growth, and international expansion.
生物医药行业定位
Axon is outside biotechnology entirely. If it appears in the database, it belongs in a broader growth-technology bucket rather than the healthcare or biotech stack.
未来催化剂
- Axon’s catalysts are software adoption, public-safety AI rollout, and continued demand for the body-cam and evidence-management ecosystem. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
近期新闻
新闻标题由机器翻译,详情为英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。
